These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15225113)

  • 1. Platelet activation in myocardial ischemic syndromes.
    Gurbel PA; Bliden KP; Hayes KM; Tantry U
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):535-45. PubMed ID: 15225113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet activation in acute coronary syndrome and interventional therapy].
    Bigalke B; Lindemann S; Gawaz M
    Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of platelet membrane glycoproteins.
    McEver RP
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):87-105. PubMed ID: 2155906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis and thrombolysis: platelet membrane glycoproteins.
    Skinner MP
    Heart Lung Circ; 2007 Jun; 16(3):176-9. PubMed ID: 17446123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of platelets for the pathophysiology of acute coronary syndromes].
    Langer H; Gawaz M
    Hamostaseologie; 2006 May; 26(2):114-8. PubMed ID: 16676053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
    Spiel AO; Gilbert JC; Jilma B
    Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
    Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
    Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between age and platelet activation in patients with stable and unstable angina.
    Gilstad JR; Gurbel PA; Andersen RE
    Arch Gerontol Geriatr; 2009; 48(2):155-9. PubMed ID: 18282622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandins and ischemic cardiopathy].
    Balsano F; Davì G; Violi F; Censi C
    G Ital Cardiol; 1992 Dec; 22(12):1427-36. PubMed ID: 1294428
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.
    Kamat SG; Schafer AI
    Coron Artery Dis; 1995 Dec; 6(12):930-5. PubMed ID: 8723014
    [No Abstract]   [Full Text] [Related]  

  • 16. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
    Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
    Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
    Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
    Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelets in atherothrombosis.
    Jennings LK
    Am J Cardiol; 2009 Feb; 103(3 Suppl):4A-10A. PubMed ID: 19166707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.